27
Participants
Start Date
December 31, 2007
Primary Completion Date
June 1, 2013
Study Completion Date
March 31, 2022
allogeneic bone marrow transplantation
Patients undergo allogeneic BMT
laboratory biomarker analysis
Correlative studies
filgrastim
Given IV
New York Medical College, Valhalla
Roswell Park Cancer Institute, Buffalo
Children's Hospital of Philadelphia, Philadelphia
University of North Carolina, Chapel Hill
Vanderbilt-Ingram Cancer Center, Nashville
Kosair Children's Hospital, Louisville
Nationwide Children's Hospital, Columbus
Indiana University Medical Center, Indianapolis
Riley Hospital for Children, Indianapolis
C S Mott Children's Hospital, Ann Arbor
Childrens Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
The Childrens Mercy Hospital, Kansas City
University of Nebraska Medical Center, Omaha
University of Texas Southwestern Medical Center, Dallas
Children's Hospital Colorado, Aurora
Primary Children's Medical Center, Salt Lake City
University of California San Francisco Medical Center-Parnassus, San Francisco
Children's Oncology Group, Arcadia
Johns Hopkins University, Baltimore
Hackensack University Medical Center, Hackensack
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK